HECTOR ROBLES: Open Payments
NPI 1548367147 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,134 in 99 payments from 22 companies in 2025. Trend: 2023 $2,352 · 2024 $1,984 · 2025 $2,134
Food & beverage: $2,134
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $333 |
| Amgen Inc. | 16 | $291 |
| Novo Nordisk Inc | 7 | $200 |
| Ardelyx, Inc. | 14 | $188 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $185 |
| Lilly USA, LLC | 10 | $182 |
| COLOPLAST CORP | 1 | $164 |
| Phathom Pharmaceuticals, Inc. | 4 | $103 |
| Abbott Laboratories | 3 | $73 |
| GlaxoSmithKline, LLC. | 4 | $70 |
Products named: FARXIGA, Ozempic, IBSRELA, Kerendia, Titan, OTEZLA, REPATHA, VOQUEZNA.
Industry payments across LA — which companies pay providers there.
